SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Floyd who wrote (125)8/2/1998 11:07:00 AM
From: Sam Lee  Read Replies (2) of 320
 
My Guess

Someone just thought it was cheap under $3. Buying has tended to fade as it nears $4. If we get a deal then the current price is dirt cheap and w/o a deal then it is just dirt.
Interesting question would be what would someone pay us for our research next Summer on breakup-if that happens. We have millions invested in productive research. It is not like we have achieved nothing to this point. We have made a lot of progress but don't quite have a marketable product. Almost, but not quite. So ARNX has some intrinsic value to someone. Question is to whom and how much.
In the mean time, I still have all of my stock--a bunch of stock. And I think we are near a deal, but believing now becomes a daily task rather than an assumption. But each has to make his own decision. Mine is now made one day at a time, but I think it will happen. I think. IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News